IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,684,000 | -44.3% | 59,700 | -30.0% | 0.06% | -44.3% |
| Q4 2020 | $4,823,000 | +68.6% | 85,300 | +41.5% | 0.11% | +35.9% |
| Q3 2020 | $2,861,000 | -38.6% | 60,300 | -23.7% | 0.08% | -42.6% |
| Q2 2020 | $4,658,000 | +0.5% | 79,000 | -19.4% | 0.14% | -19.0% |
| Q1 2020 | $4,633,000 | +28.7% | 98,000 | +64.4% | 0.17% | +63.1% |
| Q4 2019 | $3,600,000 | +63.7% | 59,600 | +62.4% | 0.10% | +58.5% |
| Q3 2019 | $2,199,000 | -6.8% | 36,700 | 0.0% | 0.06% | -4.4% |
| Q2 2019 | $2,359,000 | +200.5% | 36,700 | +8.9% | 0.07% | +240.0% |
| Q2 2016 | $785,000 | +189.7% | 33,700 | +403.0% | 0.02% | +185.7% |
| Q1 2016 | $271,000 | – | 6,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |